Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0TB2L
|
|||
| Drug Name |
PMID27607364-Compound-61
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
BAYER SCHERING PHARMA AKTIENGESELLSCHAFT LEHMANN, Lutz THIELE, Andrea HEINRICH, Tobias VOLLMER, Sonja
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C25H27FN2O4
|
|||
| Canonical SMILES |
CC1=C(C(=CC=C1)OC2=C(C=CC=N2)N(CC3=C(C=CC(=C3)OC)OCCF)C(=O)C)C
|
|||
| InChI |
1S/C25H27FN2O4/c1-17-7-5-9-23(18(17)2)32-25-22(8-6-13-27-25)28(19(3)29)16-20-15-21(30-4)10-11-24(20)31-14-12-26/h5-11,13,15H,12,14,16H2,1-4H3/i26-1
|
|||
| InChIKey |
JBDICOKSGXRRSY-KPVNRNJOSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Translocator protein (TSPO) | Target Info | Ligand | [1] |
| Target's Patent Info | Translocator protein (TSPO) | Target's Patent Info | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| HTLV-I infection | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Translocator protein (TSPO) ligands for the diagnosis or treatment of neurodegenerative diseases: a patent review (2010-2015; part 1).Expert Opin Ther Pat. 2016 Nov;26(11):1325-1351. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.